Do you often suffer from acne? Take heart, a potential vaccine that targets the bacterial toxins may soon be on the anvil, say researchers.
Health News : Instead of invading pathogens, the new vaccine would be the first to target bacteria already in human skin.
The researchers demonstrated that antibodies to a toxin secreted from bacteria in acne vulgaris can reduce inflammation in human acne lesions.
“Once validated by a large-scale clinical trial, the potential impact of our findings is huge for the hundreds of millions of individuals suffering from acne vulgaris,” explained lead investigator Chun-Ming Huang, from the University of California-San Diego, US.
An acne vaccination could circumvent potential adverse effects of topical or systemic retinoids and antibiotics, the current treatment options.
They found that Christie-Atkins-Munch-Peterson (CAMP) factor — a toxin secreted from the Propionibacterium acnes (P. acnes) bacteria, can induce inflammatory responses.
Keep Reading : BS
